Your Results
Here are clinical trials that currently enrolling participants.
Adaptive COVID-19 Cross Reactivity Study
If you had symptoms and were diagnosed with an upper respiratory infection within the past 100 days, you may be able to join a research study. Some common symptoms are cough, nasal congestion, runny nose, sore throat, and fever. If you are eligible and you complete the study, you will be paid $100 for your time.
Visit Website
Smoking Study
We are conducting a research study to learn more about the potential effects of JUUL System 5.0% nicotine products as compared to conventional cigarettes.
Visit Website
TRACTION-2 Clinical Trial of FSGS| Focal Segmental Glomerulosclerosis
The TRACTION-2 clinical research trial is evaluating an investigational product called GFB-887 for the potential treatment of focal segmental glomerulosclerosis (FSGS), treatment-resistant minimal change disease (TR-MCD), and diabetic nephropathy (DN). The purpose of the trial is to determine if GFB-887 is safe and may help people who have high levels of protein in their urine due to their kidney disease.
Visit Website
NATRON Clinical Study | Hypereosinophilic syndrome (HES)
The NATRON clinical study is researching an investigational drug for hypereosinophilic syndrome (HES) to determine if it helps to control HES when added to standard of care medications.
Visit Website
RSVP Repigmentation Study for Vitiligo Patients
If vitiligo treatments have not worked for you or have not worked well enough, you may want to consider a clinical trial, also known as a study. You can start by answering a few short questions here. You may also want to discuss this study with your doctor. He or she can help you decide if this study could be a good option for you.
Visit Website
COVID-19 Clinical Trial Connect
Would you like to participate in a research study to help better understand or find a treatment or vaccine for COVID-19? There are numerous COVID-19 research studies being conducted through the United States to track people’s symptoms, learn more about our immune response to COVID-19 and investigate potential new treatments and vaccines. Whether you are healthy, have been exposed to COVID-19, are currently experiencing symptoms, have been diagnosed or have recovered, you may be eligible to take part in a local COVID-19 research study.
Visit Website
AXLerate-OC | Now Enrolling
If you have ovarian cancer that returned after treatment, you might be uncertain about next steps. Joining a research study may be one option to consider. The AXLerate-OC study is testing an investigational* drug called batiraxcept. Researchers want to find out if this drug is safe and what effect it may have on ovarian cancer when combined with paclitaxel (a drug commonly used in ovarian cancer).
Visit Website
The LEAGUE Study for ADHD | Pediatric ADHD Clinical Research Study
The LEAGUE Study is looking at an investigational drug for ADHD. The investigational drug being evaluated is a nonstimulant but has a different mechanism of action to previous ADHD treatments
Visit Website
dreaMM8 Driving Excellence in Approaches to Multiple Myeloma
Investigating the effectiveness and safety of belantamab mafodotin in combination with pomalidomide and dexamethasone compared to pomalidomide in combination with bortezomib and dexamethasone (bor/dex) for treatment of relapsed/refractory multiple myeloma
Visit Website